Guignard A
No ORCID on file
· 2 papers in corpus
case-report
2025
INTRODUCTION: Ifosfamide, an alkylating agent, is used in treatment of various malignancies and may cause encephalopathies. The pathophysiology of this treatment adverse event is well documented, complex, and multifactorial, and involves th…
observational
2023
Following the approval of Cervarix for the immunization of girls and women in China against high-risk human papillomavirus types 16 and 18, a non-interventional post-authorization safety study was performed. A multi-center prospective cohor…